A sensitive and accurate colorimetric method was developed for the determination of the Sitagliptin phosphate monohydrate, here and after will be named Sitagliptin, in its pure and pharmaceutical form. The suggested approach is based on boosting the sensitivity of the traditional spectrometric methods by derivatizing Sitagliptin into a colored product that absorbs the visible spectrum at 573 nm. The proposed method has effectively improved the sensitivity and the limit of detection for the analysis of Sitagliptin. A linear calibration curve was obtained over the concentration range of 0.1-10 μg/ml with a correlation coefficient of 0.9983. The calculated recovery was within the range of 98.98–100.11%. While the limit of detection LOD and the limit of quantification LOQ were 0.03 mg/L and 0.1 mg/L respectively. The established procedure has been validated as exhibited linear relationship of spectroscopic absorbance intensity versus analyte concentrations and can be applied for routine quantification of the active constituent of Sitagliptin in different pharmaceuticals
Colorimetric Determination Of Sitagliptin As An Oxidation Derivative Of Ninhydrin
Sitagliptin
Sitagliptin Phosphate Monohydrate
ninhydrin
diabetes
Colorimetric determination
Publication Date
Sun Jun 05 2016
Journal Name
Baghdad Science Journal
Adiponectin , ?-Cell Dysfunction in Iraqi Women with Gestational Diabetes
"Gestational Diabetes Mellitus (GDM)
Adiponectin
Beta Cell Dysfunction
Insulin
Oral Glucose Tolerance Test (OGTT)
C-Reactive Protein (CRP). "
Gestational diabetes mellitus (GDM) is a complication of gestation that is characterized by impaired glucose tolerance with first recognition during gestation. It develops when ?- cell of pancreas fail to compensate the diminished insulin sensitivity during gestation. This study aims to investigate the relationship between mother adiponectin level and ?- cell dysfunction with development gestational diabetes mellitus (GDM) and other parameters in the last trimester of pregnancy. This study includes (80) subjects ( pregnant women) in the third trimester of pregnancy, (40) healthy pregnant individuals as control group aged between (17 - 42) years and (40) gestational diabetes mellitus patients with aged between (20 - 42) years. The f
... Show More